Variables during care of adult donors that can influence outcomes of kidney transplantation

Progress in Transplantation

Volumn 15, Issue 3, 2005, Pages 219-225

  Powner, David ^a  

^a UNIVERSITY OF TEXAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARDIOTONIC AGENT; CREATININE; DIURETIC AGENT; DOPAMINE; HETASTARCH; PLASMA SUBSTITUTE;

ADULT; BLOOD TRANSFUSION; DONOR; DRUG EFFECT; GRAFT REJECTION; GRAFT SURVIVAL; HUMAN; INFECTION CONTROL; KIDNEY; KIDNEY CIRCULATION; KIDNEY TRANSPLANTATION; METABOLIC CLEARANCE RATE; METABOLISM; METHODOLOGY; MORTALITY; PHYSIOLOGY; PREOPERATIVE CARE; REVIEW; STANDARD; TIME; TRANSPLANTATION; TREATMENT OUTCOME; URODYNAMICS;

ADULT; BLOOD TRANSFUSION; CARDIOTONIC AGENTS; CREATININE; DIURETICS; DOPAMINE; GRAFT REJECTION; GRAFT SURVIVAL; HETASTARCH; HUMANS; INFECTION CONTROL; KIDNEY; KIDNEY TRANSPLANTATION; METABOLIC CLEARANCE RATE; PLASMA SUBSTITUTES; PREOPERATIVE CARE; RENAL CIRCULATION; RESEARCH DESIGN; TIME FACTORS; TISSUE AND ORGAN PROCUREMENT; TISSUE DONORS; TREATMENT OUTCOME; URODYNAMICS;

EID: 33644675737     PISSN: 15269248     EISSN: None     Source Type: Journal    
DOI: 10.7182/prtr.15.3.r3h7n124k181g165     Document Type: Review

References (56)

1. Ramos E, Aoun S, Harmon WE. Expanding the donor pool: Effect on graft outcome. J Am Soc Nephrol. 2002;13:2590-2599.
2. Modlin CS, Goldfarb DA, Novick AC. The use of expanded criteria cadaver and live donor kidneys for transplantation. Urol Clin North Am. 2001;28:687-707.
3. Swanson SJ, Hypolite IO, Agodoa LYC, et al. Effect of donor factors on early graft survival in adult cadaveric renal transplantation. Am J Transplant. 2002;2:68-75.
4. Goldfarb-Rumyantzev AS, Scandling JD, Pappas L, Smout RJ, Horn S. Prediction of 3-yr cadaveric graft survival based on pre-Transplant variables in a large national dataset. Clin Transplant. 2003;17:485-497.
5. Port FK, Bragg-Gresham JL, Metzger RA, et al. Donor characteristics associated with reduced graft survival: An approach to expanding the pool of kidney donors. Transplantation. 2002;74:1281-1286.
6. Alexander JW, Bennett LE, Breen TJ. Effect of donor age on outcome of kidney transplantation. Transplantation. 1994; 57:871-876.
7. Chertow GM, Milford EL, Mackenzie HS, Brenner BM. Antigen-independent determinants of cadaveric kidney transplant failure. JAMA. 1996;276:1732-1736.
8. Kouli F, Morrell CH, Ratner LE, Kraus ES. Impact of donor/recipient traits independent of rejection on long-Term renal function. Am J Kidney Dis. 2001;37:356-365.
9. Pfaff WW, Howard RJ, Patton PR, Adams VR, Rosen CB, Reed AI. Delayed graft function after renal transplantation. Transplantation. 1998;65:219-223.
10. Matas AJ, Gillingham KJ, Humar A, Dunn DL, Sutherland DE, Najarian JS. Immunologic and nonimmunologic factors: Different risks for cadaver and living donor transplantation. Transplantation. 2000;69:54-58.
11. Cosio FG, Qiu W, Henry ML, et al. Factors related to the donor organ are major determinants of renal allograft function and survival. Transplantation. 1996;62:1571-1576.
12. Ojo AO, Leichtman AB, Punch JD, et al. Impact of pre-existing donor hypertension and diabetes mellitus on cadaveric renal transplant outcomes. Am J Kidney Dis. 2000;36:153-159.
13. Keitel E, Michelon T, dos Santos AF, et al. Renal transplants using expanded cadaver donor criteria. Ann Transplant. 2004; 9:23-24.
14. Cecka M. Clinical outcome of renal transplantation: Factors influencing patient and graft survival. Surg Clin North Am. 1998;78:133-148.
15. Ratner LE, Joseph V, Zibari G, et al. Transplantation of kidneys from hypertensive cadaveric donors. Transplant Proc. 1995;27:989-990.
16. Bertoni E, Zanazzi M, Rosati A, et al. Fate of kidneys retrieved from the same donor and grafted into different recipients: Do donor-related factors influence the graft outcome? Transplant Proc. 1997;29:125-126.
17. Meier-Kriesche HU, Cibrik DM, Ojo AO, et al. Interaction between donor and recipient age in determining the risk of chronic renal allograft failure. J Am Geriatr Soc. 2002;50:14-17.
18. Lucas BA, Vaughn WK, Spees EK, Sanfilippo F. Identification of donor factors predisposing to high discard rates of cadaver kidneys and increased graft loss within one year post transplantation: SEOPF 1997-1982. Transplantation. 1987; 43:253-258.
19. Terasaki PI, Gjertson DW, Cecka JM, Takemoto S, Cho YW. Significance of the donor age effect on kidney transplants. Clin Transplant. 1997;11:366-372.
20. Grekas D, Alivanis P, Derveniotis V, Papoulidou F, Kaklamanis N, Tourkantonis A. Influence of donor data on graft function after cadaveric renal transplantation. Transplant Proc. 1996;28:2957-2958.
21. Battaglia M, Ditonno P, Selvaggio O, et al. Kidney transplants from infected donors: Our experience. Transplant Proc. 2004;36:491-492.
22. Zibari GB, Lipka J, Zizzi H, Abreo KD, Jacobbi L, McDonald JC. The use of contaminated donor organs in transplantation. Clin Transplant. 2000;14:397-400.
23. Szczech LA, Coladonato JA, Owen WF. Study designs and their potential influence on conclusions. Semin Dial. 2002;15:207-211.
24. Szczech LA, Coladonato JA, Owen WF. Key concepts in biostatistics: Using statistics to answer the question "Is there a difference?" Semin Dial. 2002;15:347-351.
25. Powner DJ, Crommett JW. Advanced assessment of hemodynamic parameters during donor care. Prog Transplant. 2003;13:249-257.
26. Powner DJ, Darby JM. Management of variations in blood pressure during care of organ donors. Prog Transplant. 2000;10:25-32.
27. Powner DJ, Darby JM, Kellum JA. Proposed treatment guidelines for donor care. Prog Transplant. 2004;14:16-28.
28. Powner DJ, Kellum JA, Darby JM. Abnormalities in fluids, electrolytes, and metabolism of organ donors. Prog Transplant. 2000;10:88-96.
29. Debelak L, Pollak R, Reckard C. Arginine vasopressin versus desmopressin for the treatment of diabetes insipidus in the brain dead organ donor. Transplant Proc. 1990;22:351-352.
30. Guesde R, Barrou B, Leblanc I, et al. Administration of desmopressin in brain-dead donors and renal function in kidney recipients. Lancet. 1998;352:1178-1181.
31. Ichai C, Soubielle J, Carles M, Giunti C, Grimaud D. Comparison of the renal effects of low to high doses of dopamine and dobutamine in critically ill patients: A single-blind randomized study. Crit Care Med. 2000;28:921-928.
32. Maleck WH, Piper SN, Koetter KP. Use of dopamine in acute renal failure. Crit Care Med. 2002;30:1934-1936.
33. Australian and New Zealand Intensive Care Society Clinical Trials Group. Low-dose dopamine in patients with early renal dysfunction: A placebo-controlled randomized trial. Lancet. 2000;356:2139-2143.
34. Debaveye YA, Van den Berghe GH. Is there still a place for dopamine in the modern intensive care unit? Anesth Analg. 2004;98:461-468.
35. Kellum JA, Decker JM. Use of dopamine in acute renal failure: A meta-Analysis. Crit Care Med. 2001;29:1526-1531.
36. Cittanova ML, Leblanc I, Legendre CH, Mouquet C, Riou B, Coriat P. Effect of hydroxyethylstarch in brain-dead kidney donors on renal function in kidney-Transplant recipients. Lancet. 1996;348:1620-1622.
37. Cittanova ML, Mavre J, Riou B, Coriat P. Long-Term follow-up of transplanted kidneys according to plasma volume expander of kidney donors. Intensive Care Med. 2001;27:1830.
38. Schortgen F, Lacherade JC, Bruneel F, et al. Effects of hydroxyethylstarch and gelatin on renal function in severe sepsis: A multicentre randomized study. Lancet. 2001; 357:911-916.
39. deJonge E, Levi M, Buller HR, Berends F, Kesecioglu J. Decreased circulating levels of von Willebrand factor after intravenous administration of a rapidly degradable hydroxyethylstarch (HES 200/0.56) in healthy human subjects. Intensive Care Med. 2001;27:1825-1829.
40. Strauss RG, Pennell BJ, Stump DC. A randomized, blinded trial comparing the hemostatic effects of pentastarch versus hetastarch. Transfusion. 2002;42:27-36.
41. Deman A, Peeters P, Sennesael J. Hydroxyethyl starch does not impair immediate renal function in kidney transplant recipients: A retrospective, multicentre analysis. Nephrol Dial Transplant. 1999;14:1517-1520.
42. Boldt J. Hydroxyethylstarch as a risk factor for acute renal failure in severe sepsis. Lancet. 2001;358:581-583.
43. Neff TA, Doelberg M, Jungheinrich C, Sauerland A, Spahn DR, Stocker R. Repetitive large-dose infusion of the novel hydroxyethyl starch 130/0.4 in patients with severe head injury. Anesth Analg. 2003;96:1453:1459.
44. Kopko PM, Marshall CS, MacKenzie MR, Holland PV, Popovsky MA. Transfusion-related acute lung injury: Report of a clinical look-back investigation. JAMA. 2002;287:1968-1971.
45. Gazmuri RJ, Shakeri SA. Blood transfusion and the risk of nosocomial infection: An underreported complication? Crit Care Med. 2002;30:2389-2391.
46. Preiksaitis JK. Prevention of transfusion-Acquired CMV infection: Is there a role for NAT? Transfusion. 2003;43:302-305.
47. Weil MH. Blood transfusions. Crit Care Med. 2003;31:2397-2398.
48. Napolitano LM, Corwin HL. Efficacy of blood transfusion in the critically ill: Does age of blood make a difference? Crit Care Med. 2004;32:594-595.
49. Zallen G, Moore EE, Ciesla DJ, Brown M, Biffl WL, Silliman CC. Stored red blood cells selectively activate human neutrophils to release IL-8 and secretory PLA2. Shock. 2000;13:29-33.
50. Hebert PC, Wells G, Blajchman MA, et al. A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care. N Engl J Med. 1999;340:409-417.
51. Hebert PC, Yetisir E, Martin C, et al. Is a low transfusion safe in critically ill patients with cardiovascular diseases? Crit Care Med. 2001;29:227-234.
52. Creteur J, Vincent JL. Hemoglobin solutions. Crit Care Med. 2003;31(12 suppl):S698-S707.
53. Moore FA, McKinley BA, Moore EE. The next generation in shock resuscitation. Lancet. 2004;363:1988-1996.
54. Schnuelle P, Berger S, De Boer J, Persijn G, Van Der Woude FJ. Effects of catecholamine application to brain-dead donors on graft survival in solid organ transplantation. Transplantation. 2001;72:455-463.
55. Schnuelle P, Lorenz D, Mueller A, Trede M, Van Der Woude FJ. Donor catecholamine use reduces acute allograft rejection and improves graft survival after cadaveric renal transplantation. Kidney Int. 1999;56:738-746.
56. Decaux A, Alexandre L, Eschwege P. Does epinephrine administered in donor resuscitation influence graft renal function in the recipient? Transplant Proc. 1996;28:2889.